drugset / Trial / NCT07268586

Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

NCT07268586

Phase 4 Completed 158 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindPrevention

Summary

People with acute inferior wall myocardial infarction will be given an intravenous drug called atropine that increases the heart rate to check if it prevents heart rhythm disturbances during performing coronary intervention

Timeline

Start
2025-08-01
Primary completion
2026-02-28
Completion
2026-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 1 mg Intravenous

Indications